nodes	percent_of_prediction	percent_of_DWPC	metapath
Anagrelide—Anaemia—Ifosfamide—germ cell cancer	0.00189	0.00189	CcSEcCtD
Anagrelide—Tinnitus—Cisplatin—germ cell cancer	0.00189	0.00189	CcSEcCtD
Anagrelide—Lymphadenopathy—Methotrexate—germ cell cancer	0.00188	0.00188	CcSEcCtD
Anagrelide—Cardiac disorder—Cisplatin—germ cell cancer	0.00188	0.00188	CcSEcCtD
Anagrelide—Discomfort—Dactinomycin—germ cell cancer	0.00188	0.00188	CcSEcCtD
Anagrelide—Anorexia—Bleomycin—germ cell cancer	0.00186	0.00186	CcSEcCtD
Anagrelide—Hypoaesthesia—Etoposide—germ cell cancer	0.00184	0.00184	CcSEcCtD
Anagrelide—Malaise—Ifosfamide—germ cell cancer	0.00184	0.00184	CcSEcCtD
Anagrelide—Urinary tract disorder—Etoposide—germ cell cancer	0.00183	0.00183	CcSEcCtD
Anagrelide—Photosensitivity—Methotrexate—germ cell cancer	0.00183	0.00183	CcSEcCtD
Anagrelide—Abdominal pain—Vinblastine—germ cell cancer	0.00183	0.00183	CcSEcCtD
Anagrelide—Mediastinal disorder—Cisplatin—germ cell cancer	0.00182	0.00182	CcSEcCtD
Anagrelide—Hypotension—Bleomycin—germ cell cancer	0.00182	0.00182	CcSEcCtD
Anagrelide—Oedema—Dactinomycin—germ cell cancer	0.00182	0.00182	CcSEcCtD
Anagrelide—Urethral disorder—Etoposide—germ cell cancer	0.00182	0.00182	CcSEcCtD
Anagrelide—Infection—Dactinomycin—germ cell cancer	0.00181	0.00181	CcSEcCtD
Anagrelide—Arrhythmia—Cisplatin—germ cell cancer	0.00181	0.00181	CcSEcCtD
Anagrelide—Palpitations—Ifosfamide—germ cell cancer	0.00181	0.00181	CcSEcCtD
Anagrelide—Alopecia—Cisplatin—germ cell cancer	0.00179	0.00179	CcSEcCtD
Anagrelide—Cough—Ifosfamide—germ cell cancer	0.00178	0.00178	CcSEcCtD
Anagrelide—Thrombocytopenia—Dactinomycin—germ cell cancer	0.00178	0.00178	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.00178	0.00178	CcSEcCtD
Anagrelide—Convulsion—Ifosfamide—germ cell cancer	0.00177	0.00177	CcSEcCtD
Anagrelide—Hypertension—Ifosfamide—germ cell cancer	0.00176	0.00176	CcSEcCtD
Anagrelide—Malnutrition—Cisplatin—germ cell cancer	0.00176	0.00176	CcSEcCtD
Anagrelide—Paraesthesia—Bleomycin—germ cell cancer	0.00175	0.00175	CcSEcCtD
Anagrelide—Dyspnoea—Bleomycin—germ cell cancer	0.00174	0.00174	CcSEcCtD
Anagrelide—Chest pain—Ifosfamide—germ cell cancer	0.00174	0.00174	CcSEcCtD
Anagrelide—Myalgia—Ifosfamide—germ cell cancer	0.00174	0.00174	CcSEcCtD
Anagrelide—Arthralgia—Ifosfamide—germ cell cancer	0.00174	0.00174	CcSEcCtD
Anagrelide—Flatulence—Cisplatin—germ cell cancer	0.00174	0.00174	CcSEcCtD
Anagrelide—Anorexia—Dactinomycin—germ cell cancer	0.00173	0.00173	CcSEcCtD
Anagrelide—Eye disorder—Etoposide—germ cell cancer	0.00173	0.00173	CcSEcCtD
Anagrelide—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.00173	0.00173	CcSEcCtD
Anagrelide—Cardiac disorder—Etoposide—germ cell cancer	0.00172	0.00172	CcSEcCtD
Anagrelide—Discomfort—Ifosfamide—germ cell cancer	0.00172	0.00172	CcSEcCtD
Anagrelide—Decreased appetite—Bleomycin—germ cell cancer	0.0017	0.0017	CcSEcCtD
Anagrelide—Muscle spasms—Cisplatin—germ cell cancer	0.00169	0.00169	CcSEcCtD
Anagrelide—Confusional state—Ifosfamide—germ cell cancer	0.00168	0.00168	CcSEcCtD
Anagrelide—Mediastinal disorder—Etoposide—germ cell cancer	0.00167	0.00167	CcSEcCtD
Anagrelide—Pain—Bleomycin—germ cell cancer	0.00167	0.00167	CcSEcCtD
Anagrelide—Oedema—Ifosfamide—germ cell cancer	0.00167	0.00167	CcSEcCtD
Anagrelide—Chills—Etoposide—germ cell cancer	0.00166	0.00166	CcSEcCtD
Anagrelide—Vision blurred—Cisplatin—germ cell cancer	0.00166	0.00166	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.00166	0.00166	CcSEcCtD
Anagrelide—Asthenia—Vinblastine—germ cell cancer	0.00166	0.00166	CcSEcCtD
Anagrelide—Infection—Ifosfamide—germ cell cancer	0.00166	0.00166	CcSEcCtD
Anagrelide—Alopecia—Etoposide—germ cell cancer	0.00164	0.00164	CcSEcCtD
Anagrelide—Cerebrovascular accident—Methotrexate—germ cell cancer	0.00164	0.00164	CcSEcCtD
Anagrelide—Nervous system disorder—Ifosfamide—germ cell cancer	0.00164	0.00164	CcSEcCtD
Anagrelide—Ill-defined disorder—Cisplatin—germ cell cancer	0.00163	0.00163	CcSEcCtD
Anagrelide—Thrombocytopenia—Ifosfamide—germ cell cancer	0.00163	0.00163	CcSEcCtD
Anagrelide—Anaemia—Cisplatin—germ cell cancer	0.00163	0.00163	CcSEcCtD
Anagrelide—Skin disorder—Ifosfamide—germ cell cancer	0.00162	0.00162	CcSEcCtD
Anagrelide—Hyperhidrosis—Ifosfamide—germ cell cancer	0.00161	0.00161	CcSEcCtD
Anagrelide—Feeling abnormal—Bleomycin—germ cell cancer	0.00161	0.00161	CcSEcCtD
Anagrelide—Osteoarthritis—Methotrexate—germ cell cancer	0.00161	0.00161	CcSEcCtD
Anagrelide—Anorexia—Ifosfamide—germ cell cancer	0.00159	0.00159	CcSEcCtD
Anagrelide—Malaise—Cisplatin—germ cell cancer	0.00159	0.00159	CcSEcCtD
Anagrelide—Decreased appetite—Dactinomycin—germ cell cancer	0.00158	0.00158	CcSEcCtD
Anagrelide—Diarrhoea—Vinblastine—germ cell cancer	0.00158	0.00158	CcSEcCtD
Anagrelide—Fatigue—Dactinomycin—germ cell cancer	0.00157	0.00157	CcSEcCtD
Anagrelide—Back pain—Etoposide—germ cell cancer	0.00156	0.00156	CcSEcCtD
Anagrelide—Hypotension—Ifosfamide—germ cell cancer	0.00156	0.00156	CcSEcCtD
Anagrelide—Pain—Dactinomycin—germ cell cancer	0.00156	0.00156	CcSEcCtD
Anagrelide—Muscle spasms—Etoposide—germ cell cancer	0.00155	0.00155	CcSEcCtD
Anagrelide—Urticaria—Bleomycin—germ cell cancer	0.00155	0.00155	CcSEcCtD
Anagrelide—Body temperature increased—Bleomycin—germ cell cancer	0.00154	0.00154	CcSEcCtD
Anagrelide—Dizziness—Vinblastine—germ cell cancer	0.00153	0.00153	CcSEcCtD
Anagrelide—Convulsion—Cisplatin—germ cell cancer	0.00153	0.00153	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.00152	0.00152	CcSEcCtD
Anagrelide—Myalgia—Cisplatin—germ cell cancer	0.0015	0.0015	CcSEcCtD
Anagrelide—Feeling abnormal—Dactinomycin—germ cell cancer	0.0015	0.0015	CcSEcCtD
Anagrelide—Paraesthesia—Ifosfamide—germ cell cancer	0.0015	0.0015	CcSEcCtD
Anagrelide—Ill-defined disorder—Etoposide—germ cell cancer	0.0015	0.0015	CcSEcCtD
Anagrelide—Anaemia—Etoposide—germ cell cancer	0.00149	0.00149	CcSEcCtD
Anagrelide—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.00149	0.00149	CcSEcCtD
Anagrelide—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.00149	0.00149	CcSEcCtD
Anagrelide—Dyspnoea—Ifosfamide—germ cell cancer	0.00149	0.00149	CcSEcCtD
Anagrelide—Somnolence—Ifosfamide—germ cell cancer	0.00148	0.00148	CcSEcCtD
Anagrelide—Liver function test abnormal—Methotrexate—germ cell cancer	0.00148	0.00148	CcSEcCtD
Anagrelide—Discomfort—Cisplatin—germ cell cancer	0.00148	0.00148	CcSEcCtD
Anagrelide—Vomiting—Vinblastine—germ cell cancer	0.00147	0.00147	CcSEcCtD
Anagrelide—Malaise—Etoposide—germ cell cancer	0.00146	0.00146	CcSEcCtD
Anagrelide—Decreased appetite—Ifosfamide—germ cell cancer	0.00145	0.00145	CcSEcCtD
Anagrelide—Headache—Vinblastine—germ cell cancer	0.00145	0.00145	CcSEcCtD
Anagrelide—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.00144	0.00144	CcSEcCtD
Anagrelide—Abdominal pain—Dactinomycin—germ cell cancer	0.00144	0.00144	CcSEcCtD
Anagrelide—Body temperature increased—Dactinomycin—germ cell cancer	0.00144	0.00144	CcSEcCtD
Anagrelide—Fatigue—Ifosfamide—germ cell cancer	0.00144	0.00144	CcSEcCtD
Anagrelide—Oedema—Cisplatin—germ cell cancer	0.00144	0.00144	CcSEcCtD
Anagrelide—Infection—Cisplatin—germ cell cancer	0.00143	0.00143	CcSEcCtD
Anagrelide—Constipation—Ifosfamide—germ cell cancer	0.00143	0.00143	CcSEcCtD
Anagrelide—Pain—Ifosfamide—germ cell cancer	0.00143	0.00143	CcSEcCtD
Anagrelide—Loss of consciousness—Etoposide—germ cell cancer	0.00142	0.00142	CcSEcCtD
Anagrelide—Nervous system disorder—Cisplatin—germ cell cancer	0.00141	0.00141	CcSEcCtD
Anagrelide—Cough—Etoposide—germ cell cancer	0.00141	0.00141	CcSEcCtD
Anagrelide—Thrombocytopenia—Cisplatin—germ cell cancer	0.00141	0.00141	CcSEcCtD
Anagrelide—Tachycardia—Cisplatin—germ cell cancer	0.0014	0.0014	CcSEcCtD
Anagrelide—Asthenia—Bleomycin—germ cell cancer	0.0014	0.0014	CcSEcCtD
Anagrelide—Convulsion—Etoposide—germ cell cancer	0.0014	0.0014	CcSEcCtD
Anagrelide—Skin disorder—Cisplatin—germ cell cancer	0.0014	0.0014	CcSEcCtD
Anagrelide—Hypertension—Etoposide—germ cell cancer	0.00139	0.00139	CcSEcCtD
Anagrelide—Hyperhidrosis—Cisplatin—germ cell cancer	0.00139	0.00139	CcSEcCtD
Anagrelide—Asthma—Methotrexate—germ cell cancer	0.00139	0.00139	CcSEcCtD
Anagrelide—Pruritus—Bleomycin—germ cell cancer	0.00138	0.00138	CcSEcCtD
Anagrelide—Feeling abnormal—Ifosfamide—germ cell cancer	0.00137	0.00137	CcSEcCtD
Anagrelide—Chest pain—Etoposide—germ cell cancer	0.00137	0.00137	CcSEcCtD
Anagrelide—Nausea—Vinblastine—germ cell cancer	0.00137	0.00137	CcSEcCtD
Anagrelide—Anorexia—Cisplatin—germ cell cancer	0.00137	0.00137	CcSEcCtD
Anagrelide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.00136	0.00136	CcSEcCtD
Anagrelide—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.00136	0.00136	CcSEcCtD
Anagrelide—Pancreatitis—Methotrexate—germ cell cancer	0.00136	0.00136	CcSEcCtD
Anagrelide—Discomfort—Etoposide—germ cell cancer	0.00136	0.00136	CcSEcCtD
Anagrelide—Hypotension—Cisplatin—germ cell cancer	0.00134	0.00134	CcSEcCtD
Anagrelide—Abdominal discomfort—Methotrexate—germ cell cancer	0.00133	0.00133	CcSEcCtD
Anagrelide—Confusional state—Etoposide—germ cell cancer	0.00133	0.00133	CcSEcCtD
Anagrelide—Urticaria—Ifosfamide—germ cell cancer	0.00132	0.00132	CcSEcCtD
Anagrelide—Body temperature increased—Ifosfamide—germ cell cancer	0.00132	0.00132	CcSEcCtD
Anagrelide—Abdominal pain—Ifosfamide—germ cell cancer	0.00132	0.00132	CcSEcCtD
Anagrelide—Pancytopenia—Methotrexate—germ cell cancer	0.00132	0.00132	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.00131	0.00131	CcSEcCtD
Anagrelide—Infection—Etoposide—germ cell cancer	0.00131	0.00131	CcSEcCtD
Anagrelide—Asthenia—Dactinomycin—germ cell cancer	0.00131	0.00131	CcSEcCtD
Anagrelide—Dysuria—Methotrexate—germ cell cancer	0.0013	0.0013	CcSEcCtD
Anagrelide—Paraesthesia—Cisplatin—germ cell cancer	0.00129	0.00129	CcSEcCtD
Anagrelide—Thrombocytopenia—Etoposide—germ cell cancer	0.00129	0.00129	CcSEcCtD
Anagrelide—Tachycardia—Etoposide—germ cell cancer	0.00129	0.00129	CcSEcCtD
Anagrelide—Dyspnoea—Cisplatin—germ cell cancer	0.00128	0.00128	CcSEcCtD
Anagrelide—Skin disorder—Etoposide—germ cell cancer	0.00128	0.00128	CcSEcCtD
Anagrelide—Erectile dysfunction—Methotrexate—germ cell cancer	0.00128	0.00128	CcSEcCtD
Anagrelide—Hyperhidrosis—Etoposide—germ cell cancer	0.00127	0.00127	CcSEcCtD
Anagrelide—Photosensitivity reaction—Methotrexate—germ cell cancer	0.00127	0.00127	CcSEcCtD
Anagrelide—Anorexia—Etoposide—germ cell cancer	0.00126	0.00126	CcSEcCtD
Anagrelide—Decreased appetite—Cisplatin—germ cell cancer	0.00125	0.00125	CcSEcCtD
Anagrelide—Diarrhoea—Dactinomycin—germ cell cancer	0.00125	0.00125	CcSEcCtD
Anagrelide—Pneumonia—Methotrexate—germ cell cancer	0.00124	0.00124	CcSEcCtD
Anagrelide—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.00124	0.00124	CcSEcCtD
Anagrelide—Vomiting—Bleomycin—germ cell cancer	0.00124	0.00124	CcSEcCtD
Anagrelide—Depression—Methotrexate—germ cell cancer	0.00123	0.00123	CcSEcCtD
Anagrelide—Hypotension—Etoposide—germ cell cancer	0.00123	0.00123	CcSEcCtD
Anagrelide—Rash—Bleomycin—germ cell cancer	0.00123	0.00123	CcSEcCtD
Anagrelide—Pain—Cisplatin—germ cell cancer	0.00123	0.00123	CcSEcCtD
Anagrelide—Dermatitis—Bleomycin—germ cell cancer	0.00123	0.00123	CcSEcCtD
Anagrelide—Renal failure—Methotrexate—germ cell cancer	0.00122	0.00122	CcSEcCtD
Anagrelide—Conjunctivitis—Methotrexate—germ cell cancer	0.0012	0.0012	CcSEcCtD
Anagrelide—Asthenia—Ifosfamide—germ cell cancer	0.0012	0.0012	CcSEcCtD
Anagrelide—Sweating—Methotrexate—germ cell cancer	0.00119	0.00119	CcSEcCtD
Anagrelide—Feeling abnormal—Cisplatin—germ cell cancer	0.00118	0.00118	CcSEcCtD
Anagrelide—Paraesthesia—Etoposide—germ cell cancer	0.00118	0.00118	CcSEcCtD
Anagrelide—Pruritus—Ifosfamide—germ cell cancer	0.00118	0.00118	CcSEcCtD
Anagrelide—Haematuria—Methotrexate—germ cell cancer	0.00118	0.00118	CcSEcCtD
Anagrelide—Dyspnoea—Etoposide—germ cell cancer	0.00117	0.00117	CcSEcCtD
Anagrelide—Somnolence—Etoposide—germ cell cancer	0.00117	0.00117	CcSEcCtD
Anagrelide—Hepatobiliary disease—Methotrexate—germ cell cancer	0.00117	0.00117	CcSEcCtD
Anagrelide—Epistaxis—Methotrexate—germ cell cancer	0.00117	0.00117	CcSEcCtD
Anagrelide—Nausea—Bleomycin—germ cell cancer	0.00116	0.00116	CcSEcCtD
Anagrelide—Vomiting—Dactinomycin—germ cell cancer	0.00116	0.00116	CcSEcCtD
Anagrelide—Rash—Dactinomycin—germ cell cancer	0.00115	0.00115	CcSEcCtD
Anagrelide—Decreased appetite—Etoposide—germ cell cancer	0.00115	0.00115	CcSEcCtD
Anagrelide—Diarrhoea—Ifosfamide—germ cell cancer	0.00114	0.00114	CcSEcCtD
Anagrelide—Gastrointestinal disorder—Etoposide—germ cell cancer	0.00114	0.00114	CcSEcCtD
Anagrelide—Body temperature increased—Cisplatin—germ cell cancer	0.00114	0.00114	CcSEcCtD
Anagrelide—Fatigue—Etoposide—germ cell cancer	0.00114	0.00114	CcSEcCtD
Anagrelide—Pain—Etoposide—germ cell cancer	0.00113	0.00113	CcSEcCtD
Anagrelide—Constipation—Etoposide—germ cell cancer	0.00113	0.00113	CcSEcCtD
Anagrelide—Haemoglobin—Methotrexate—germ cell cancer	0.00112	0.00112	CcSEcCtD
Anagrelide—Haemorrhage—Methotrexate—germ cell cancer	0.00111	0.00111	CcSEcCtD
Anagrelide—Hepatitis—Methotrexate—germ cell cancer	0.00111	0.00111	CcSEcCtD
Anagrelide—Dizziness—Ifosfamide—germ cell cancer	0.0011	0.0011	CcSEcCtD
Anagrelide—Pharyngitis—Methotrexate—germ cell cancer	0.0011	0.0011	CcSEcCtD
Anagrelide—Urinary tract disorder—Methotrexate—germ cell cancer	0.0011	0.0011	CcSEcCtD
Anagrelide—Urethral disorder—Methotrexate—germ cell cancer	0.00109	0.00109	CcSEcCtD
Anagrelide—Feeling abnormal—Etoposide—germ cell cancer	0.00109	0.00109	CcSEcCtD
Anagrelide—Nausea—Dactinomycin—germ cell cancer	0.00108	0.00108	CcSEcCtD
Anagrelide—Gastrointestinal pain—Etoposide—germ cell cancer	0.00108	0.00108	CcSEcCtD
Anagrelide—Visual impairment—Methotrexate—germ cell cancer	0.00107	0.00107	CcSEcCtD
Anagrelide—Vomiting—Ifosfamide—germ cell cancer	0.00106	0.00106	CcSEcCtD
Anagrelide—Rash—Ifosfamide—germ cell cancer	0.00105	0.00105	CcSEcCtD
Anagrelide—Dermatitis—Ifosfamide—germ cell cancer	0.00105	0.00105	CcSEcCtD
Anagrelide—Urticaria—Etoposide—germ cell cancer	0.00105	0.00105	CcSEcCtD
Anagrelide—Abdominal pain—Etoposide—germ cell cancer	0.00104	0.00104	CcSEcCtD
Anagrelide—Body temperature increased—Etoposide—germ cell cancer	0.00104	0.00104	CcSEcCtD
Anagrelide—Eye disorder—Methotrexate—germ cell cancer	0.00104	0.00104	CcSEcCtD
Anagrelide—Tinnitus—Methotrexate—germ cell cancer	0.00104	0.00104	CcSEcCtD
Anagrelide—Asthenia—Cisplatin—germ cell cancer	0.00103	0.00103	CcSEcCtD
Anagrelide—Cardiac disorder—Methotrexate—germ cell cancer	0.00103	0.00103	CcSEcCtD
Anagrelide—Mediastinal disorder—Methotrexate—germ cell cancer	0.001	0.001	CcSEcCtD
Anagrelide—Chills—Methotrexate—germ cell cancer	0.000997	0.000997	CcSEcCtD
Anagrelide—Nausea—Ifosfamide—germ cell cancer	0.000991	0.000991	CcSEcCtD
Anagrelide—Diarrhoea—Cisplatin—germ cell cancer	0.000984	0.000984	CcSEcCtD
Anagrelide—Alopecia—Methotrexate—germ cell cancer	0.000981	0.000981	CcSEcCtD
Anagrelide—Malnutrition—Methotrexate—germ cell cancer	0.000967	0.000967	CcSEcCtD
Anagrelide—Asthenia—Etoposide—germ cell cancer	0.000945	0.000945	CcSEcCtD
Anagrelide—Back pain—Methotrexate—germ cell cancer	0.000935	0.000935	CcSEcCtD
Anagrelide—Pruritus—Etoposide—germ cell cancer	0.000932	0.000932	CcSEcCtD
Anagrelide—Vomiting—Cisplatin—germ cell cancer	0.000914	0.000914	CcSEcCtD
Anagrelide—Vision blurred—Methotrexate—germ cell cancer	0.000911	0.000911	CcSEcCtD
Anagrelide—Rash—Cisplatin—germ cell cancer	0.000907	0.000907	CcSEcCtD
Anagrelide—Dermatitis—Cisplatin—germ cell cancer	0.000906	0.000906	CcSEcCtD
Anagrelide—Diarrhoea—Etoposide—germ cell cancer	0.000901	0.000901	CcSEcCtD
Anagrelide—Ill-defined disorder—Methotrexate—germ cell cancer	0.000897	0.000897	CcSEcCtD
Anagrelide—Anaemia—Methotrexate—germ cell cancer	0.000894	0.000894	CcSEcCtD
Anagrelide—Malaise—Methotrexate—germ cell cancer	0.000872	0.000872	CcSEcCtD
Anagrelide—Dizziness—Etoposide—germ cell cancer	0.000871	0.000871	CcSEcCtD
Anagrelide—Nausea—Cisplatin—germ cell cancer	0.000854	0.000854	CcSEcCtD
Anagrelide—Cough—Methotrexate—germ cell cancer	0.000844	0.000844	CcSEcCtD
Anagrelide—Convulsion—Methotrexate—germ cell cancer	0.000838	0.000838	CcSEcCtD
Anagrelide—Vomiting—Etoposide—germ cell cancer	0.000838	0.000838	CcSEcCtD
Anagrelide—Rash—Etoposide—germ cell cancer	0.000831	0.000831	CcSEcCtD
Anagrelide—Dermatitis—Etoposide—germ cell cancer	0.00083	0.00083	CcSEcCtD
Anagrelide—Headache—Etoposide—germ cell cancer	0.000825	0.000825	CcSEcCtD
Anagrelide—Chest pain—Methotrexate—germ cell cancer	0.000823	0.000823	CcSEcCtD
Anagrelide—Myalgia—Methotrexate—germ cell cancer	0.000823	0.000823	CcSEcCtD
Anagrelide—Arthralgia—Methotrexate—germ cell cancer	0.000823	0.000823	CcSEcCtD
Anagrelide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000817	0.000817	CcSEcCtD
Anagrelide—Discomfort—Methotrexate—germ cell cancer	0.000813	0.000813	CcSEcCtD
Anagrelide—Confusional state—Methotrexate—germ cell cancer	0.000796	0.000796	CcSEcCtD
Anagrelide—Infection—Methotrexate—germ cell cancer	0.000784	0.000784	CcSEcCtD
Anagrelide—Nausea—Etoposide—germ cell cancer	0.000782	0.000782	CcSEcCtD
Anagrelide—Nervous system disorder—Methotrexate—germ cell cancer	0.000774	0.000774	CcSEcCtD
Anagrelide—Thrombocytopenia—Methotrexate—germ cell cancer	0.000773	0.000773	CcSEcCtD
Anagrelide—Skin disorder—Methotrexate—germ cell cancer	0.000766	0.000766	CcSEcCtD
Anagrelide—Hyperhidrosis—Methotrexate—germ cell cancer	0.000763	0.000763	CcSEcCtD
Anagrelide—Anorexia—Methotrexate—germ cell cancer	0.000752	0.000752	CcSEcCtD
Anagrelide—Hypotension—Methotrexate—germ cell cancer	0.000737	0.000737	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000719	0.000719	CcSEcCtD
Anagrelide—Insomnia—Methotrexate—germ cell cancer	0.000714	0.000714	CcSEcCtD
Anagrelide—Paraesthesia—Methotrexate—germ cell cancer	0.000709	0.000709	CcSEcCtD
Anagrelide—Dyspnoea—Methotrexate—germ cell cancer	0.000703	0.000703	CcSEcCtD
Anagrelide—Somnolence—Methotrexate—germ cell cancer	0.000701	0.000701	CcSEcCtD
Anagrelide—Dyspepsia—Methotrexate—germ cell cancer	0.000695	0.000695	CcSEcCtD
Anagrelide—Decreased appetite—Methotrexate—germ cell cancer	0.000686	0.000686	CcSEcCtD
Anagrelide—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000681	0.000681	CcSEcCtD
Anagrelide—Fatigue—Methotrexate—germ cell cancer	0.00068	0.00068	CcSEcCtD
Anagrelide—Pain—Methotrexate—germ cell cancer	0.000675	0.000675	CcSEcCtD
Anagrelide—Feeling abnormal—Methotrexate—germ cell cancer	0.00065	0.00065	CcSEcCtD
Anagrelide—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000645	0.000645	CcSEcCtD
Anagrelide—Urticaria—Methotrexate—germ cell cancer	0.000627	0.000627	CcSEcCtD
Anagrelide—Abdominal pain—Methotrexate—germ cell cancer	0.000624	0.000624	CcSEcCtD
Anagrelide—Body temperature increased—Methotrexate—germ cell cancer	0.000624	0.000624	CcSEcCtD
Anagrelide—Asthenia—Methotrexate—germ cell cancer	0.000566	0.000566	CcSEcCtD
Anagrelide—Pruritus—Methotrexate—germ cell cancer	0.000558	0.000558	CcSEcCtD
Anagrelide—Diarrhoea—Methotrexate—germ cell cancer	0.00054	0.00054	CcSEcCtD
Anagrelide—Dizziness—Methotrexate—germ cell cancer	0.000522	0.000522	CcSEcCtD
Anagrelide—Vomiting—Methotrexate—germ cell cancer	0.000502	0.000502	CcSEcCtD
Anagrelide—Rash—Methotrexate—germ cell cancer	0.000497	0.000497	CcSEcCtD
Anagrelide—Dermatitis—Methotrexate—germ cell cancer	0.000497	0.000497	CcSEcCtD
Anagrelide—Headache—Methotrexate—germ cell cancer	0.000494	0.000494	CcSEcCtD
Anagrelide—Nausea—Methotrexate—germ cell cancer	0.000469	0.000469	CcSEcCtD
